Medición del impacto de intervenciones médicas a nivel individual

Translated title of the contribution: Evaluation of individual clinical outcomes in medical interventions

Francisco Lopez-Jimenez, Luis Eduardo P Rohde, Samuel Ponce-de-León-Rosales

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Medical interventions have a variable response among individuals. It is desirable to detect patients who are getting a therapeutic benefit. Any medical intervention has to show a favorable effect in survival and/or control of symptoms in order to be considered useful. In many clinical scenarios, laboratory test results are not enough to be confident of the effectiveness of a treatment. In order to do a clinical evaluation focused on patients' interests, we suggest the use of instruments to measure quality of life. Currently there are quality of life scales that have undergone a rigorous process of validation and reliability. Sub-group analysis is frequently used to predict an individual benefit of medical interventions. In the interpretation of sub-group analysis, it is important to be aware of the risk of misinterpretation, making false positive or false negative conclusions about the effect of the treatment. The N-of-1 trial is a valid scientific alternative to define individual effectiveness of therapy. Defining the degree of therapeutic benefit timely we avoid useless therapies, unnecessary side effects, and sequelae secondary to the lack of opportune treatment.

Original languageSpanish
Pages (from-to)379-386
Number of pages8
JournalRevista de Investigacion Clinica
Volume49
Issue number5
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Therapeutics
Quality of Life
Survival

Keywords

  • Effectiveness
  • Quality of life
  • Randomized clinical trial
  • Side effects
  • Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Medición del impacto de intervenciones médicas a nivel individual. / Lopez-Jimenez, Francisco; Rohde, Luis Eduardo P; Ponce-de-León-Rosales, Samuel.

In: Revista de Investigacion Clinica, Vol. 49, No. 5, 09.1997, p. 379-386.

Research output: Contribution to journalArticle

Lopez-Jimenez, F, Rohde, LEP & Ponce-de-León-Rosales, S 1997, 'Medición del impacto de intervenciones médicas a nivel individual', Revista de Investigacion Clinica, vol. 49, no. 5, pp. 379-386.
Lopez-Jimenez, Francisco ; Rohde, Luis Eduardo P ; Ponce-de-León-Rosales, Samuel. / Medición del impacto de intervenciones médicas a nivel individual. In: Revista de Investigacion Clinica. 1997 ; Vol. 49, No. 5. pp. 379-386.
@article{b4d0540eb66f4edeab51f5c2ef024607,
title = "Medici{\'o}n del impacto de intervenciones m{\'e}dicas a nivel individual",
abstract = "Medical interventions have a variable response among individuals. It is desirable to detect patients who are getting a therapeutic benefit. Any medical intervention has to show a favorable effect in survival and/or control of symptoms in order to be considered useful. In many clinical scenarios, laboratory test results are not enough to be confident of the effectiveness of a treatment. In order to do a clinical evaluation focused on patients' interests, we suggest the use of instruments to measure quality of life. Currently there are quality of life scales that have undergone a rigorous process of validation and reliability. Sub-group analysis is frequently used to predict an individual benefit of medical interventions. In the interpretation of sub-group analysis, it is important to be aware of the risk of misinterpretation, making false positive or false negative conclusions about the effect of the treatment. The N-of-1 trial is a valid scientific alternative to define individual effectiveness of therapy. Defining the degree of therapeutic benefit timely we avoid useless therapies, unnecessary side effects, and sequelae secondary to the lack of opportune treatment.",
keywords = "Effectiveness, Quality of life, Randomized clinical trial, Side effects, Therapy",
author = "Francisco Lopez-Jimenez and Rohde, {Luis Eduardo P} and Samuel Ponce-de-Le{\'o}n-Rosales",
year = "1997",
month = "9",
language = "Spanish",
volume = "49",
pages = "379--386",
journal = "Revista de Investigacion Clinica",
issn = "0034-8376",
publisher = "Instituto Nacional de la Nutricion Salvador Zubiran",
number = "5",

}

TY - JOUR

T1 - Medición del impacto de intervenciones médicas a nivel individual

AU - Lopez-Jimenez, Francisco

AU - Rohde, Luis Eduardo P

AU - Ponce-de-León-Rosales, Samuel

PY - 1997/9

Y1 - 1997/9

N2 - Medical interventions have a variable response among individuals. It is desirable to detect patients who are getting a therapeutic benefit. Any medical intervention has to show a favorable effect in survival and/or control of symptoms in order to be considered useful. In many clinical scenarios, laboratory test results are not enough to be confident of the effectiveness of a treatment. In order to do a clinical evaluation focused on patients' interests, we suggest the use of instruments to measure quality of life. Currently there are quality of life scales that have undergone a rigorous process of validation and reliability. Sub-group analysis is frequently used to predict an individual benefit of medical interventions. In the interpretation of sub-group analysis, it is important to be aware of the risk of misinterpretation, making false positive or false negative conclusions about the effect of the treatment. The N-of-1 trial is a valid scientific alternative to define individual effectiveness of therapy. Defining the degree of therapeutic benefit timely we avoid useless therapies, unnecessary side effects, and sequelae secondary to the lack of opportune treatment.

AB - Medical interventions have a variable response among individuals. It is desirable to detect patients who are getting a therapeutic benefit. Any medical intervention has to show a favorable effect in survival and/or control of symptoms in order to be considered useful. In many clinical scenarios, laboratory test results are not enough to be confident of the effectiveness of a treatment. In order to do a clinical evaluation focused on patients' interests, we suggest the use of instruments to measure quality of life. Currently there are quality of life scales that have undergone a rigorous process of validation and reliability. Sub-group analysis is frequently used to predict an individual benefit of medical interventions. In the interpretation of sub-group analysis, it is important to be aware of the risk of misinterpretation, making false positive or false negative conclusions about the effect of the treatment. The N-of-1 trial is a valid scientific alternative to define individual effectiveness of therapy. Defining the degree of therapeutic benefit timely we avoid useless therapies, unnecessary side effects, and sequelae secondary to the lack of opportune treatment.

KW - Effectiveness

KW - Quality of life

KW - Randomized clinical trial

KW - Side effects

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0141827841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141827841&partnerID=8YFLogxK

M3 - Article

C2 - 9527698

AN - SCOPUS:0141827841

VL - 49

SP - 379

EP - 386

JO - Revista de Investigacion Clinica

JF - Revista de Investigacion Clinica

SN - 0034-8376

IS - 5

ER -